Tom Boone

Biography

Tom Boone has more than 28 years of accomplishments in the discovery and development of protein therapeutics. Prior to helping found REMD Biotherapeutics, Tom worked at Amgen and served in positions of increasing responsibility in growing Amgen Protein Sciences to an organization of over 300 researchers across five different sites while maintaining a long tradition of industry excellence. His career at Amgen began in 1981 with the isolation and cDNA cloning of novel cytokines and growth factors including G-CSF. Tom Boone’s responsibilities grew from Scientist to Director and he developed proprietary processes used to produce recombinant G-CSF and other therapeutic candidates for clinical applications. His continuing success led to leadership of all research protein technologies, and the evolution of Protein Sciences as an independent organization. Tom Boone was the first Vice President of Amgen Protein Science and his teams were responsible for the majority of the current Amgen product portfolio and late stage clinical programs. Tom was the inventor and a lead scientist in the development of Nplate®, a treatment of thrombocytopenia. His critical role in the discovery and process development of G-CSF (Neupogen) is widely recognized. Tom Boone’s expertise in protein engineering, production, purification and process development are in high demand. In addition to his responsibilities at REMD, he serves as a consultant or scientific advisor to more than 10 different companies and investment group.

Research Interest

Protein engineering